NOVAVAX INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NOVAVAX INC stock issued during period, value, stock options exercised for fiscal 2013 was $1.50M, a 2674.07% increase from fiscal 2012.
- NOVAVAX INC stock issued during period, value, stock options exercised for fiscal 2012 was $54.00K, a 69.83% decline from fiscal 2011.
- NOVAVAX INC stock issued during period, value, stock options exercised for fiscal 2011 was $179.00K, a 57.98% decline from fiscal 2010.
- NOVAVAX INC stock issued during period, value, stock options exercised for fiscal 2010 was $426.00K, a 55.25% decline from fiscal 2009.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2013-12-31 | $1.50M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $54.00K 10-K · filed 2015-02-27 | |
| 2011-12-31 | $179.00K 10-K · filed 2014-03-12 | |
| 2010-12-31 | $426.00K 10-K · filed 2013-03-12 | |
| 2009-12-31 | $952.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |